Additional radiation effect on cell viability using neutron irradiated Cisplatin and Carboplatin: preliminary results

Additional radiation effect on cell viability using neutron irradiated Cisplatin and Carboplatin: preliminary results

The objective of this work was to investigate the effect on cell viability of radiolabeled complexes of cisplatin and carboplatin in cancer cells of the 4T1 and MDA-MB-231 lines from mice with mammary carcinoma. The complexes were labeled in the CDTN's TRIGA Mark I nuclear research reactor aft...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alexandre Soares Leal, Juliana B Silva, Ana Olivia G Morais, Brigida Gomes de Almeida Schirmer
Format:	Article
Language:	English
Published:	Brazilian Radiation Protection Society (Sociedade Brasileira de Proteção Radiológica, SBPR) 2025-02-01
Series:	Brazilian Journal of Radiation Sciences
Subjects:	Cisplatin carboplatin radiochemotherapy antitumoral effects
Online Access:	https://bjrs.org.br/revista/index.php/REVISTA/article/view/2614
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of concurrent chemoradiation with cisplatin versus concurrent chemoradiation with carboplatin in locally advanced carcinoma cervix: A quasi-experimental study
by: Syed Md. Asadul Hoque, et al.
Published: (2025-05-01)

PENURUNAN NILAI HANTARAN TULANG PADA PENDERITA KARSINOMA NASOFARING DENGAN KEMOTERAPI BERBASIS PLATINUM: KOMBINASI NEOADJUVANT PACLITAXEL-CISPLATIN DAN PACLITAXEL-CARBOPLATIN
by: Cika Apriliana, et al.
Published: (2019-02-01)

Carboplatin hypersensitivity in relapsed ovarian carcinoma: A therapeutic challenge
by: Avinash Pandey, et al.
Published: (2014-01-01)

Internal computational dosimetry of natural cisplatin activated in neutron flux
by: Giovana Bussolotti, et al.
Published: (2022-07-01)

Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer
by: Shao-Jing Wang, et al.
Published: (2025-03-01)

The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer
by: Shu Kato, et al.
Published: (2025-04-01)

L-Threonine-Derived Biodegradable Polyurethane Nanoparticles for Sustained Carboplatin Release
by: Seoeun Oh, et al.
Published: (2024-12-01)

The treatment of stage A testicular seminoma by carboplatin monochemotherapy
by: Bojanić Nebojša, et al.
Published: (2009-01-01)

Molecular pharmacokinetic mechanism of quercetin-encapsulated polymeric micelles in alleviating cisplatin-induced nephrotoxicity and enhancing antineoplastic effects
by: Tangna Hao, et al.
Published: (2025-06-01)

Population pharmacokinetics modelling for clinical dose adjustment of carboplatin in dogs
by: Jérémy Béguin, et al.
Published: (2024-12-01)

The real-world safety profile of pemetrexed and platinum with or without pembrolizumab: insights from a comparative analysis of FAERS database
by: Shun Li, et al.
Published: (2025-04-01)

Exploring Sex-Based Neuropsychological Outcomes in Pediatric Brain Cancer Survivors: A Pilot Study
by: Chiara Colliva, et al.
Published: (2024-11-01)

Dual inhibition of AKT and autophagy sensitizes triple negative breast cancer cells to carboplatin
by: Jun-zhen Zhou, et al.
Published: (2025-08-01)

LAMC3 interference reduces drug resistance of carboplatin-resistant ovarian cancer cells
by: Xia Liu, et al.
Published: (2025-07-01)

Impact of adding carboplatin to docetaxel chemotherapy on testosterone levels and treatment outcomes in metastatic docetaxel-resistant prostate cancer
by: Hejar Atalan, et al.
Published: (2025-06-01)

Acute pancreatitis caused by pemetrexed, carboplatin, and gemcitabine in a patient with lung cancer: A rare case report
by: Vishal Kulkarni, et al.
Published: (2019-01-01)

Antitumor Activity of Dehydroxymethylepoxychinomycin (DHMEQ) and Cisplatin Combination in a Model of Disseminated Ovarian Cancer
by: Sh. R. Kzyrgalin, et al.
Published: (2023-10-01)

Carboplatin combined with arsenic trioxide versus carboplatin combined with docetaxel treatment for LACC: A randomized, open-label, phase II clinical study
by: Li Sijin, et al.
Published: (2024-12-01)

Study on the mechanisms and functions of lncRNAs in regulating carboplatin resistance in ovarian cancer cells
by: HONG Yi, et al.
Published: (2025-02-01)

Real-world safety of carboplatin in non-small cell lung cancer: a retrospective signal detection and subgroup analysis based on the FAERS database
by: Lei Wang, et al.
Published: (2025-06-01)

Optimization of lymphatic drug delivery system with carboplatin for metastatic lymph nodes
by: Miriu Miyatsu, et al.
Published: (2025-05-01)

Consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology on the management of muscle-invasive and advanced urothelial carcinoma
by: Darren M.C. Poon, et al.
Published: (2025-05-01)

THEM6 modulates carboplatin sensitivity by regulating ferroptosis through FDFT1 in triple-negative breast cancer
by: Yuexiang Zeng, et al.
Published: (2025-07-01)

Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancer
by: Shuwen Dong, et al.
Published: (2025-01-01)

Germ cell quantification in human fetal and prepubertal testis tissues: a comparison of current methodologies
by: Emma Kearney, et al.
Published: (2025-02-01)

Improvement of carboplatin chemosensitivity in lung cancer cells by siRNA-mediated downregulation of DLGAP1-AS2 expression
by: Sania Ghobadi Alamdari, et al.
Published: (2025-03-01)

Immunotherapy in the complex treatment of tumor diseases
by: V. I. Seledtsov, et al.
Published: (2022-05-01)

Evaluation of patient management of (radio-)chemotherapy-caused mucositis with the goal of enhancing patient treatment
by: Helena Wolff, et al.
Published: (2025-07-01)

Cost-effectiveness analysis of penpulimab plus carboplatin-paclitaxel as first-line treatment for metastatic squamous non-small-cell lung cancer in China
by: Luwei Wang, et al.
Published: (2025-07-01)

Influence of the estimated glomerular filtration rate equation on carboplatin dosing: a real-world study
by: Ana Rita Fortunato, et al.
Published: (2025-06-01)

Hyperfractionated radiotherapy with concurrent weekly paclitaxel and carboplatin for locally advanced unresectable head and neck squamous cell carcinoma
by: Perumal S, et al.
Published: (2025-06-01)

IGF2BP3‐dependent N6‐methyladenosine modification of USP49 promotes carboplatin resistance in retinoblastoma by enhancing autophagy via regulating the stabilization of SIRT1
by: Lei Li, et al.
Published: (2024-12-01)

Structural, Electronic and Topological Properties of Carboplatin Conjugate with Fullerenol
by: A. L. Pushkarchuk, et al.
Published: (2025-02-01)

Cisplatin and the Dissolution of Electrodes in Electrochemistry Experiments
by: Ross Milton, et al.
Published: (2025-02-01)

Nanotherapeutic interventions to enhance cisplatin sensitivity in ovarian cancer cells
by: Disha Mittal, et al.
Published: (2025-08-01)

Enhancing the Efficacy of Melanoma Treatment: The In Vitro Chemosensitising Impact of <i>Vipera ammodytes</i> Venom on Human Melanoma Cell Lines
by: Giovanni Paolino, et al.
Published: (2025-03-01)

Altered frontotemporal glucose metabolism following radiotherapy and/or chemotherapy for cervical cancer
by: Yao Hu, et al.
Published: (2025-06-01)

Quantitative analysis of plasma DNA in anal cancer patients
by: Ewa Małusecka, et al.
Published: (2022-06-01)

Amelioration of cisplatin-induced hepatotoxicity by statins in rats
by: R A Maheshwari, et al.
Published: (2015-01-01)

PERBANDINGAN KEJADIAN LEUKOPENIA DAN TROMBOSITOPENIA PADA PENDERTIA KARSINOMA NASOFARING YANG MENDAPATKAN KEMOTERAPI PACLITAXEL CISPLATIN DAN CISPLATIN 5-FLUOROURACIL (5-FU)
by: Nadya Tara Audina, et al.
Published: (2019-10-01)